Capital Formation

New York – October 29, 2026 -- Formation Bio, an AI-native pharmaceutical company, has launched the Formation Bio Drug Development Accelerator Fund with $600 million in capital commitments to expand its portfolio of clinical-stage medicines. The company aims to acquire 10-15 drug programs over the next 3-5 years and advance them through key clinical milestones.

Fund draws research foundations, endowments and hospitals as limited partners

The Fund's limited partners include research foundations, institutional endowments, hospitals and philanthropic organizations. Formation Bio acts as general partner through a wholly owned subsidiary and has committed its own capital alongside them. The amount of that commitment was not disclosed.

The Fund exclusively finances the acquisition and development of programs within Formation Bio's portfolio, scaling the company's hub-and-spoke model.

Jakarta – October 09, 2026 -- The New Asia Forum has set a US$30 billion investment target for its inaugural edition, to be held 3-4 December in Bali, Indonesia, under the patronage of Indonesian President Prabowo Subianto.

Danantara Indonesia and Richard Attias & Associates launch a transaction-focused platform

The forum is powered by Danantara Indonesia, the country's sovereign fund, and produced by Richard Attias & Associates. Organizers describe it as a gateway connecting long-term capital with projects, partnerships and policymakers across the region.

It is built around transaction readiness, capital deployment and execution rather than a traditional conference format. The US$30 billion target will be pursued through a curated pipeline of investment-ready opportunities, with heads of state, ministers, sovereign investors and global CEOs aiming to convert diligence into signed commitments.

Minneapolis – September 21, 2026 -- Proterra Investment Partners has hired Jennie Park as Head of Capital Formation and appointed Matt Coad as Head of Investor Solutions, expanding leadership as the food value chain-focused alternative asset manager grows its institutional investor base.

Park joins from H.I.G. Capital, a $75 billion global alternative investment firm

At H.I.G. Capital, Park served as a Principal responsible for capital raising and investor relations across the firm's credit strategies in North America. She previously held Managing Director roles at Briarcliffe Credit Partners focused on private credit fundraising, and led North American business development and investor relations at Vantage Infrastructure. Earlier stops include Apollo Global Management, Anchorage Capital, and leveraged finance at Goldman Sachs, where she began her career.

Los Angeles – September 18, 2026 -- Vance Street Capital has appointed Katherine Dowley as Head of Investor Relations, expanding its institutional capabilities following the $775 million close of Vance Street Capital IV in 2024.

Firm brings total capital raised past $2 billion after latest fund close

The Los Angeles-based private equity firm, which invests in founder-owned and family businesses as well as corporate carve-outs across industrial, medical and life science, and aerospace and defense markets, closed its fourth fund at its hard cap of $775 million in 2024. That closing pushed total capital raised by Vance Street to more than $2 billion.

Newark, N.J. – September 16, 2026 -- HarbourView Equity Partners, a music and entertainment-focused investment firm managing approximately $3.88 billion in regulatory assets, has appointed Patrick Morin as Managing Director of Business Development, tasking him with leading capital formation and investor partnerships.

Morin brings 25 years of institutional investment experience to the role

Morin previously served as Managing Director at Cambridge Associates, where he oversaw Healthcare and Regional Endowments & Foundations Client Solutions. He held prior roles in investment banking, wealth advisory, and alternative investments at Citi, Merrill Lynch, and Morgan Stanley.

His background includes managing alternative investments for high-net-worth and family office clients, overseeing commission-based sales and trading operations, and leading investor relations at firms focused on credit, merger arbitrage, and event-driven strategies.